April 14, 2021

A Pause on the Johnson & Johnson Vaccine

by The Journal

Six cases of a rare blood clotting disorder have led U.S. health officials to pause the use of Johnson & Johnson's Covid-19 vaccine. Though it's not known if the vaccine is behind the blood clotting, WSJ's Jonathan D. Rockoff says the pause could impact efforts to vaccinate the country.

Where to Listen